首页> 外文期刊>Technology in cancer research & treatment. >Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy
【24h】

Pelvic Lymph Node Irradiation Including Pararectal Sentinel Nodes for Prostate Cancer Patients: Treatment Optimization Comparing Intensity Modulated X-rays, Volumetric Modulated Arc Therapy, and Intensity Modulated Proton Therapy

机译:盆腔淋巴结辐照,包括前列腺癌前列腺癌患者的哨子节点:治疗优化比较强度调制X射线,体积调制弧治疗和强度调制质子疗法

获取原文
           

摘要

We aimed to assess the dosimetric impact of advanced delivery radiotherapy techniques using either intensity modulated x-ray beams (IMXT), volumetric modulated arc therapy (VMAT), or intensity modulated proton therapy (IMPT), for high-risk prostate cancer patients with sentinel nodes in the pararectal region. Twenty high-risk prostate cancer patients were included in a prospective trial evaluating sentinel nodes on pelvic SPECT acquisition. To be eligible for the dosimetric study, patients had to present with pararectal sentinel nodes usually not included in the clinical target volume encompassing the pelvic lymph nodes. Radiotherapy-plans including the prostate, the seminal vesicles, and the pelvic lymph nodes with the pararectal sentinel nodes were optimized for 6 eligible patients. IMXT and IMPT were delivered with 7 and 3 beams respectively and VMAT with 2 arcs. Results were assessed with Dose-Volume Histograms and predictive normal tissue complication probabilities (NTCPs) models between the three competing treatment modalities aiming to deliver a total dose of 50.4 Gy in 1.8 Gy daily fractions. Target coverage was optimized with IMPT when compared to IMXT and VMAT. Coverage of the sentinel node was slightly better with IMXT (D98% 5 57.3 ± 5.1 Gy) when compared with VMAT (D98% 5 56.2 ± 4.1 Gy). The irradiation of rectal, bladder, small bowel, and femoral heads volumes was significantly reduced with IMPT when compared to IMXT and VMAT. NTCPs rates for rectal and bladder ≥ grade-3 late toxicity were better with IMPT (0.4 ± 0.0% and 0.0 ± 0.0%) compared with IMXT (4.6 ± 3.3% and 1.4 ± 1.1%), and VMAT (4.5 ± 4.0% and 1.6 ± 1.6%), respectively. Acceptable dose-volume distributions and low rectal and urinary NTCPs were estimated to geometrically complex pelvic volumes such as the ones proposed in this study using IMXT, VMAT and IMPT. IMPT succeeded, however, to propose the best physical and biological treatment plans compared to both X-ray derived plans.
机译:我们旨在评估使用强度调制X射线束(IMXT),体积调制的ARC疗法(VMAT)或强度调制质子治疗(IMPT)的高级递送放射疗法技术的剂量造成的对哨兵的高危前列腺癌患者处于每条地区的节点。 20名高风险的前列腺癌患者被包含在骨盆SPECT获取的前瞻性试验中评估哨兵节点。要符合剂量测定研究,患者必须呈现通常不包括在包含盆腔淋巴结的临床目标体积中的每条哨兵哨节点。针对6名合格患者进行了优化了包括前列腺,精髓囊泡和盆腔淋巴结节点的放射疗法 - 计划。 IMXT和IMPT分别用7和3个光束和2个弧线的VMAT传送。使用剂量直方图和预测性正常组织并发症概率(NTCPS)在三个竞争的治疗方式之间进行评估结果,其旨在在1.8GY的每日级分中提供50.4 Gy的总剂量。与IMXT和VMAT相比,目标覆盖率通过IMPT进行了优化。与VMAT相比,IMXT的覆盖率略微较好,IMXT(D98%5 57.3±5.1 GY)(D98%5 56.2±4.1 GY)。与IMXT和VMAT相比,直肠,膀胱,小肠和股骨头和股骨头体积的照射显着降低。与IMPT相比,直肠和膀胱的NTCPS≥1级晚期毒性≥1级晚毒性更好(0.4±0.0%和0.0±0.0%)和VMAT(4.5±4.0%)和VMAT(4.5±4.0%)(4.5±4.0%)分别为1.6±1.6%)。可接受的剂量分布和低直肠和尿液NTCP估计到几何复杂的骨盆体积,例如使用IMXT,VMAT和IMPT在本研究中提出的骨盆体积。然而,与X射线衍生的计划相比,IMPT成功地提出了最好的物理和生物学处理计划。

著录项

相似文献

  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号